Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gloom Amidst Contract Research Boom

This article was originally published in PharmAsia News

Executive Summary

According to conservative estimates, China's contract research organization market has hit 4 billion yuan and is expanding at 100 percent annually. However, the breakneck development is curtailed by the shortage of talent with practical experience, high investments in research facilities, and ignorance on intellectual property rights. Industry experts suggest that domestic CROs can succeed only when they ensure international-level education and training, proper legal structure, and focused marketing development. They should also form a more competitive local team and concentrate on early stage drug development, as well as preclinical and Phase I and II clinical trials to take advantage of domestic resources. (Click here for more)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC065942

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel